Unlock stock picks and a broker-level newsfeed that powers Wall Street.
The 3 Best Robotics Stocks to Buy in January 2024

In This Article:

One very promising and innovative area of technology is robotics. Finding the best robotics stocks is not only a stroke of luck for savvy investors looking to exploit this highly-growing industry. It is an adventure into world automation and artificial intelligence. These organizations are pioneering the use of advanced robotic technology in transforming various industries such as manufacturing and health. It is an intersection where innovation meets pragmatism, giving the world some spectacular breakthroughs and for those wise ones who invest in them – a future of bright financial prospects.

Diving deeper, we find a land quite diverse, filled with companies excelling at different niches of the robotics domain. Each contributes uniquely, offering sophisticated software, innovative hardware, or path-breaking integration systems.

This diversity not only drives the industry’s development but also offers investors with different choices. The range of options from established giants who are emerging with promising new technologies to nimble start-ups that shake tradition shows the dynamism of this sector. In this constantly changing environment, the best way to uncover value is by realizing each competitor’s specific advantages and possibilities. With this in mind, let’s examine three high-quality plays in the robotics field.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Stryker Corp. (SYK)

The Stryker (SYK) office in Fremont, California.
The Stryker (SYK) office in Fremont, California.

Source: Sundry Photography / Shutterstock.com

Stryker Corporation (NYSE:SYK) is a medical technology giant, known for its advances in robotics and continuing to make improvements and accomplishments in the industry. It has proven a solid market player in the past five years churning out an impressive 85% return.

Furthermore, the third quarter of this year SYK reported a significant increase in revenue to $4.91 billion, as opposed to 83% from previous quarters. However, it also disclosed a 15% loss in net income of $692 million. These figures reveal the dynamic financial atmosphere in which growth and challenges simultaneously take place.

In the medical field, one should also consider a promising move into robotics by the company including Mako SmartRobotics system. This innovative orthopedic surgery technology has revolutionized the whole scenario by providing precision and improved clinical outcomes. Stryker Corporation seems to devote much to this field, as seen from its R&D activities, which ensures further robotics developments. Such initiatives have considerably helped the financial success of the company, per its continued use of Mako surgical robots.